A vaccine that wards off the common Epstein-Barr virus to potentially prevent glandular fever, multiple sclerosis and even some cancers has shown promise in mice, ferrets and monkeys
BSIP SA/Alamy
at ModeX Therapeutics in Natick, Massachusetts, and his colleagues developed a vaccine that exposes the body to two proteins that Epstein-Barr virus uses to invade cells, training the immune system to recognise the pathogen if exposed. “It was a very promising result because we were able to basically block the virus infection almost entirely and stop it from causing even low-level infection,” says Nabel.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Ex-prosecutor says Bill Barr has 'incriminating evidence' about TrumpA former federal prosecutor says Bill Barr can provide 'directly incriminating evidence' about Trump's false claims of election fraud
Les mer »
Flu vaccine could cut COVID riskA study of over 30,000 health-care workers in Qatar found that those who got the flu vaccine were also protected from COVID-19 — but the effect might not last long
Les mer »
Flu vaccine could cut COVID riskA study of over 30,000 health-care workers in Qatar found that those who got the flu vaccine were also protected from COVID-19 — but the effect might not last long
Les mer »
US Surgeon General: Monkeypox virus may be transmissible through sexual contactThe United State’s Surgeon General is saying the new outbreak of the monkeypox virus is something we need to be aware of, but not necessarily to worry about.
Les mer »
Joe Biden on monkeypox: 'Everybody should be concerned'President Biden said efforts were being made to investigate whether a vaccine would be developed to combat against monkeypox.
Les mer »
Which Sunscreen Should You Stock Up on This Summer?Which Sunscreen Should You Stock Up on This Summer? To help you choose the best lotion or spray, Consumer Reports puts dozens of them to the test.
Les mer »